Sustainable weight loss with personalized semaglutide dosing
New research being presented at the European Congress on Obesity (ECO) in Venice, Italy (12-15 May) has explored the benefits ...
Tag: Glucagon
How safe are GLP-1R agonists in early pregnancy?
A new study published in JAMA Internal Medicine examines the safety of glucagon-like peptide 1 (GLP-1) receptor agonists, along with ...
Groundbreaking studies indicate Semaglutide and Tirzepatide may reduce alcohol consumption in individuals with obesity
In a recent study published in Scientific Reports, researchers evaluated the impact of semaglutide and tirzepatide medications on alcohol consumption ...
New study shows circulating anti-insulin CD4 T cells reflect progression of anti-islet immunity
Type 1 diabetes (T1D) is an autoimmune disease linked to helper T-cell recognition in non-obese diabetic (NOD) mice and humans. ...
Oral semaglutide outperforms other medications in type 2 diabetes treatment, significantly reducing HbA1c and body weight
A study analyzing the PIONEER trial data claims that orally administered semaglutide is highly effective in reducing glycated hemoglobin (HbA1c) ...
New Clinical Practice Guideline offers recommendations to manage hypoglycemia in people with diabetes
People with diabetes are benefiting from advances in medications and technologies to lower their risk of hypoglycemia, according to a ...
